Atossa Therapeutics ATOS
NASDAQ ATOS
$2.34 +0.07 (+3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Asset Writedowns and Impairment (2018 - 2024)

Updated

Atossa Therapeutics (ATOS) posted Asset Writedowns and Impairment of $1.71 million for FY2024, down 43.0% from $3 million in FY2023.

Analysis

Atossa Therapeutics (ATOS) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends

Since FY2013, Atossa Therapeutics has reported Asset Writedowns and Impairment for 5 years.

  • The FY2024 figure stands as the lowest annual Asset Writedowns and Impairment since FY2017.
  • Business Quant data shows ATOS's Asset Writedowns and Impairment at $3 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Atossa Therapeutics 23.35 Mn 23.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.71 Mn
Mar 31, 2019 1.74 Mn
Dec 31, 2018 -2.18 Mn
Sep 30, 2018 623,496.00
API Access

Atossa Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ATOS&period=max&api_key=YOUR_API_KEY